Brickell Stock Future Price Prediction


USD 0.12  0.00  0.00%   

Brickell Biotech stock price prediction is an act of determining the future value of Brickell Biotech shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Brickell Biotech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Brickell Biotech and does not consider all of the tangible or intangible factors available from Brickell Biotech's fundamental data. We analyze noise-free headlines and recent hype associated with Brickell Biotech, which may create opportunities for some arbitrage if properly timed.
Continue to Brickell Biotech Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Brickell Biotech based on different types of headlines from major news networks to social media. The Brickell stock price prediction module provides an analysis of price elasticity to changes in media outlook on Brickell Biotech over a specific investment horizon.
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Brickell Biotech hype-based prediction, you can estimate the value of Brickell Biotech from the perspective of Brickell Biotech response to recently generated media hype and the effects of current headlines on its competitors.
Brickell Biotech Accrued Expenses Turnover is most likely to slightly decrease in the upcoming years. The last year's value of Accrued Expenses Turnover was reported at 0.52. The current Cash and Equivalents Turnover is estimated to increase to 0.08, while Operating Margin is projected to decrease to (120.19) .
This module is based on analyzing investor sentiment around taking a position in Brickell Biotech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Brickell Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Brickell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Brickell Biotech after-hype prediction price

  $ 0.12  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brickell Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brickell Biotech in the context of predictive analytics.
LowReal ValueHigh
1 Analysts
LowTarget PriceHigh
Estimates (1)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brickell Biotech. Your research has to be compared to or analyzed against Brickell Biotech's peers to derive any actionable benefits. When done correctly, Brickell Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brickell Biotech.

Brickell Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of Brickell Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Brickell Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Brickell Biotech, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Brickell Biotech Estimiated After-Hype Price Volatility

In the context of predicting Brickell Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Brickell Biotech's historical news coverage. Brickell Biotech's after-hype downside and upside margins for the prediction period are 0.01 and 7.48, respectively. We have considered Brickell Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.12
After-hype Price
Brickell Biotech is abnormally volatile asset. Analysis and calculation of next after-hype price of Brickell Biotech is based on 3 months time horizon.

Brickell Biotech Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Brickell Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brickell Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Brickell Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.10  7.30  0.00    0.40  3 Events / Month8 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility 

Brickell Biotech Hype Timeline

On the 28th of June Brickell Biotech is traded for 0.12. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.4. Brickell forecasted not to react to the next headlinewith price going to stay at about the same level and average media hype impact volatility of about 0.0%. The immediate return on the next newsis forecasted to be very small whereas the daily expected return is currently at -1.1%. The volatility of relative hype elasticity to Brickell Biotech is about 1983.7%. The volatility of related hype on Brickell Biotech is about 1983.7% with expected price after next announcement by competition of -0.28. About 17.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. Brickell Biotech recorded a loss per share of 0.62. The entity had not issued any dividends in recent years. The firm had a split on the 3rd of September 2019. Considering the 90-day investment horizon the next forecastedpress releasewill be in about 3 days.
Continue to Brickell Biotech Basic Forecasting Models to cross-verify your projections.

Brickell Biotech Related Hype Analysis

Having access to credible news sources related to Brickell Biotech's direct competition is more important than ever and may enhance your ability to predict Brickell Biotech's future price movements. Getting to know how Brickell Biotech rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Brickell Biotech may potentially react to the hype associated with one of its peers.
At Risk
ABEOAbeona Therapeutics(0.05) 5 per month 0.00 (0.09)  11.76 (10.00)  24.81 
ABIOArca Biopharma 0.05 9 per month 2.08  0.09  4.31 (3.40)  12.15 
PLSQFPlus500 0.00 4 per month 0.00  0.53  0.00  0.00  2.47 
IBMInternational Business Machines 0.64 11 per month 1.40  0.19  2.47 (2.47)  11.05 
HDHome Depot(9.61) 9 per month 0.00 (0.009)  2.92 (3.54)  8.63 
WMTWalmart 0.34 7 per month 0.00 (0.0233)  2.43 (2.47)  13.98 
CVXChevron Corp 0.1 8 per month 0.00 (0.0062)  3.06 (4.60)  10.25 
AAAlcoa Corp 2.84 8 per month 0.00 (0.18)  5.10 (6.70)  21.93 
PGProcter Gamble(0.36) 11 per month 0.00  0.043  2.54 (2.30)  8.89 
BABoeing Company 2.37 10 per month 0.00 (0.07)  5.64 (5.07)  16.31 

Brickell Biotech Additional Predictive Modules

Most predictive techniques to examine Brickell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Brickell using various technical indicators. When you analyze Brickell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Brickell Biotech Predictive Indicators

The successful prediction of Brickell Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Brickell Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Brickell Biotech based on analysis of Brickell Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Brickell Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Brickell Biotech's related companies.
 2017 2018 2021 2022 (projected)
Accounts Payable Turnover17.962.02.32.36
PPandE Turnover15.544.594.144.69

Story Coverage note for Brickell Biotech

The number of cover stories for Brickell Biotech depends on current market conditions and Brickell Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Brickell Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Brickell Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Brickell Biotech Short Properties

Brickell Biotech's future price predictability will typically decrease when Brickell Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Brickell Biotech often depends not only on the future outlook of the potential Brickell Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brickell Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out3.53%
Short Percent Of Float3.61%
Float Shares111.7M
Shares Short Prior Month2.58M
Average Daily Volume Last 10 Day3.08M
Average Daily Volume In Three Month5.64M
Date Short Interest29th of April 2022
Continue to Brickell Biotech Basic Forecasting Models to cross-verify your projections. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
14.8 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.